Product image of Irbesartán Sandoz (Irbesartan) supplied by GNH India

Irbesartán Sandoz

Active Ingredient:
Irbesartan
Origin:
EU

Irbesartán Sandoz (Irbesartan)

Irbesartan, the active ingredient in Irbesartán Sandoz, is a Angiotensin II receptor blocker (ARB) presented as an oral tablet for oral use. It treats hypertension and diabetic nephropathy in adult patients.

GNH India supplies Irbesartán Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Sandoz Farmacéutica, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Irbesartan is an ARB that acts on the renin‑angiotensin‑aldosterone system to control blood pressure and protect the kidneys.

  • Hypertension: lowers elevated blood pressure and reduces cardiovascular risk.
  • Diabetic nephropathy: slows the progression of kidney damage in patients with type 2 diabetes.
  • Proteinuria: decreases urinary protein excretion, contributing to renal protection.

How It Works

  • Irbesartan selectively blocks angiotensin II type 1 (AT1) receptors, preventing angiotensin II‑mediated vasoconstriction and aldosterone release. This results in vasodilation, reduced peripheral resistance, and decreased sodium and water retention, thereby lowering blood pressure and offering renal protective effects in diabetic patients.

Side Effects

Common Side Effects

  • Dizziness: sensation of light‑headedness, especially after standing.
  • Headache: mild to moderate pain in the head region.
  • Fatigue: feeling unusually tired or weak.
  • Nausea: upset stomach with possible vomiting.
  • Abdominal pain: discomfort in the stomach area.
  • Cough: occasional dry throat irritation.

Serious or Rare Side Effects

  • Angioedema: swelling of face, lips, tongue, or throat requiring immediate medical attention.
  • Hyperkalaemia: elevated blood potassium that can affect heart rhythm.
  • Acute renal impairment: sudden decline in kidney function.
  • Severe hypotension: markedly low blood pressure causing faintness.
  • Hepatic injury: abnormal liver enzymes or jaundice.
  • Neutropenia: low white‑blood‑cell count increasing infection risk.

Precautions & Warnings

Before initiating therapy, clinicians should consider several safety measures.

  • Blood pressure monitoring: ensure adequate control and avoid excessive drops.
  • Renal function assessment: check serum creatinine and eGFR regularly.
  • Serum potassium checks: monitor for hyperkalaemia, especially with concomitant potassium‑sparing agents.
  • Pregnancy avoidance: contraindicated in pregnancy due to fetal toxicity risk.
  • Elderly caution: start at lower doses and titrate slowly.
  • Store at below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Irbesartan may interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Aliskiren (in diabetes): combined use can increase renal dysfunction and hyperkalaemia.
  • ACE inhibitors or other ARBs: concurrent use raises risk of hypotension and potassium excess.
  • Potassium‑sparing diuretics: may cause dangerous hyperkalaemia.
  • NSAIDs (e.g., ibuprofen): can impair renal function and blunt antihypertensive effect.

Moderate Interactions (Monitor Closely)

  • Thiazide diuretics: additive blood‑pressure lowering effect, monitor for hypotension.
  • Lithium: may increase lithium concentrations, watch for signs of toxicity.
  • CYP2C9 inhibitors (e.g., fluconazole): can raise irbesartan plasma levels, consider dose adjustment.

Frequently Asked Questions

Irbesartán Sandoz contains irbesartan, an angiotensin II receptor blocker indicated for the treatment of hypertension and for slowing the progression of diabetic nephropathy in adult patients.

Irbesartan selectively blocks AT1 receptors, preventing angiotensin II from causing vasoconstriction and aldosterone release. This leads to vessel relaxation, reduced blood pressure, and decreased kidney stress in diabetic patients.

The appropriate dose is determined by the prescribing clinician based on the individual’s blood‑pressure goals, renal function, and overall health status. Patients should follow the prescriber’s instructions precisely.

Irbesartan is classified as pregnancy category D because it can cause fetal harm. It should be discontinued before conception and is not recommended while breastfeeding. Women of child‑bearing potential should use effective contraception.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Irbesartan belongs to the ARB class, offering blood‑pressure control similar to ACE inhibitors but with a lower incidence of cough and angioedema. Compared with calcium‑channel blockers, ARBs act on the renin‑angiotensin system rather than directly relaxing vascular smooth muscle.

Store the tablets at temperatures below 25 °C in their original container, protecting them from moisture and direct sunlight. Do not expose the product to excessive heat or humidity to maintain potency.

Irbesartán Sandoz is taken orally, usually once daily with or without food. Patients should swallow the tablet whole with a glass of water and follow the dosing schedule prescribed by their healthcare provider.

Serious risks include angioedema, severe hyperkalaemia, acute renal impairment, and marked hypotension. Patients should seek immediate medical attention if they experience swelling of the face or throat, rapid heartbeat, or a sudden drop in blood pressure.

Irbesartan is contraindicated in patients with known hypersensitivity to the drug, in pregnant women, and in individuals with severe hepatic impairment. Caution is advised for patients with renal artery stenosis or those taking potassium‑increasing medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Irbesartan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT